Does Wegovy Affect Periods, and What Should You Expect?

The myth worth clearing up first: Wegovy doesn't directly target your hormones

The most common misconception about Wegovy and periods is that semaglutide somehow switches off reproductive hormones, acting on the cycle in its own right. It doesn't work that way. Semaglutide is a GLP-1 receptor agonist that works primarily on appetite and blood-sugar regulation, it was not designed to alter oestrogen, progesterone or the hormonal rhythm that drives menstruation. Letting that worry go is a reasonable starting point.

What does happen, in some women, is that losing a meaningful amount of weight relatively quickly can change how the body regulates sex hormones. Fat tissue plays an active role in oestrogen production and metabolism, so when body composition shifts (particularly in women with higher starting weights) the hormonal environment can shift with it. That is the more likely explanation for period changes on Wegovy, and understanding it changes how you should interpret what you notice.

The Wegovy clinical programme did not identify menstrual disruption as a primary adverse effect of semaglutide, and the NHS patient information for semaglutide does not list missed or irregular periods among the commonly reported side effects, though people sometimes ask whether semaglutide causes body odour and other subtle physical changes as they get used to treatment. Any changes you notice are worth recording, but they rarely point to a problem with the medicine itself.

How weight loss can shift your cycle (and what to watch for

Weight loss of around five to ten percent of body weight) well within the range many people experience in the early months of Wegovy treatment, is enough to disrupt the hypothalamic-pituitary-ovarian axis in some women. The result can be lighter periods, irregular timing, or periods that pause for a month or two before settling into a new pattern. This is recognised in clinical practice and is distinct from conditions such as polycystic ovary syndrome (PCOS), though women with PCOS sometimes notice that weight loss improves cycle regularity rather than disrupts it.

Rapid weight loss also places the body under a degree of physiological stress. Calorie restriction, reduced fat mass and changes in insulin sensitivity can all contribute to shifts in luteinising hormone (LH) and follicle-stimulating hormone (FSH) levels, the signals that time ovulation. If those signals become irregular, so can the cycle. Most women find that their periods stabilise as weight loss slows and their body adapts.

One practical point: if your periods stop or become very infrequent, do not assume you cannot become pregnant. Ovulation can still occur unpredictably during hormonal adjustment. NHS guidance on how Wegovy can affect your period is worth reviewing alongside advice from your GP, particularly if you are using hormonal contraception.

Contraception and semaglutide: what the evidence actually says

Semaglutide slows gastric emptying, which raises a question about whether it reduces absorption of oral contraceptive pills. The clinical picture here is genuinely reassuring compared to tirzepatide (Mounjaro). NHS England's guidance notes that the concern about pill absorption applies specifically to tirzepatide, and that there is no equivalent body of evidence indicating the same effect with semaglutide. If you are on the combined or progestogen-only pill and taking Wegovy, there is currently no requirement to add a barrier method for the first weeks of treatment, but telling your prescriber you are taking both medicines is still the right step.

Fertility is a separate conversation. Weight-related hormonal changes mean some women become more fertile as they lose weight, not less. If you are not trying to conceive, a reliable method of contraception remains important throughout treatment. Questions about Wegovy and periods often sit alongside questions about fertility, both are worth raising at consultation. For a broader look at what Wegovy does to your period specifically, we've written a detailed companion piece.

A note on cost: if you are weighing up private treatment, our Wegovy price comparison guide explains what UK providers typically charge and what those prices do and do not include, without any hidden figures.

When to speak to a clinician, and what counts as normal

Short-term changes to your cycle in the first two to four months of treatment are common and usually benign. A period that arrives a week late, is lighter than usual, or skips once is not, by itself, a clinical emergency.

Contact your GP or prescriber promptly if any of the following apply: your periods stop entirely for three or more months; you experience unusually heavy bleeding or significant pain; you suspect you might be pregnant; you have a history of conditions affecting the uterus or ovaries that could be complicated by hormonal shifts. Women with PCOS, endometriosis, or irregular cycles before starting treatment should flag this during their initial clinical assessment, it shapes how changes later on are interpreted.

A question our prescribers hear often is whether semaglutide causes complete cessation of periods. In the vast majority of cases, it does not, but whether semaglutide can stop periods altogether depends heavily on the individual's starting weight, the pace of weight loss, and their hormonal baseline. There is also some curiosity about whether Wegovy can trigger a period in women who were previously experiencing disruption due to obesity, and for some, particularly those with PCOS, the answer is yes. A prescriber who knows your history is the right person to make sense of whichever direction things go.

If you would like a clinician to review your situation before or during treatment, you can check your eligibility with our prescribers, a real clinician reads every consultation the same day.